Search for: "Lilly v. Virginia" Results 21 - 40 of 96
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 May 2011, 4:54 am by Marie Louise
ARUP: Genetic testing patents found to be anticipated and in violation of Lilly written description requirement (Holman’s Biotech IP Blog) (Patent Docs) (Patently-O) US: FDA gets the ball rolling on biosimilar/interchangeable biological product user fee program; proposal gives a hat tip to PDUFA while acknowledging the nascent state of the industry (FDA Law Blog) (Patent Docs) Products Citalopram – UK Patents Court disapproving of EPO’s approach to assessment of novelty:… [read post]
6 Jul 2007, 4:29 am
We've already deplored the recent decision of the West Virginia Supreme Court rejecting the learned intermediary rule outright, State ex rel. [read post]
21 Sep 2020, 9:18 am by Goldstein & Stamm, P.A.
Virginia (1996)(striking down VMI’s male-only admissions policy); Olmstead v. [read post]
21 Mar 2016, 3:44 am by Amy Howe
  First up is Wittman v. [read post]
3 Mar 2016, 5:19 am
  Early in this blog’s existence, in 2007, the West Virginia Supreme Court in State ex rel. [read post]
27 Dec 2006, 1:14 pm
Lilly Lois Hamilton In Virginia Hartman and Suzanne Swinehart v. [read post]
20 Mar 2009, 2:05 am
Eli Lilly & Co., 774 F.2d 830, 835 (7th Cir. 1985); Martinkovic v. [read post]
9 Jun 2011, 10:02 am by Bexis
Eli Lilly & Co., 2009 WL 5216930, at *12 (E.D.N.Y. [read post]
22 Jun 2018, 3:18 am
  If you missed on part 1, you can find it here.Yes Virginia, there is IP practice outside of London: a special interview. [read post]